Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations (MAV-IRM)

NCT02896881 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.

NCT NCT02896881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02896881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of New MRI Sequences After Embolization of Brain Arteriovenous Malformations (MAV-IRM)
Lead sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Phase
Observational
Overall status
Terminated
Start date
February 1, 2017
Completion date
February 3, 2025
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain arteriovenous malformations